RHOC and cancer: We assess the hypothesis that RhoC amplifies interferon signaling and thereby increases junction dysregulation, consequently promoting cancer cells’ motility and invasiveness; this work supports inhibition of RhoC as a potential therapeutic strategy in aggressive cancers.